{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:46:42Z","timestamp":1776872802085,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1KL2TR002374"],"award-info":[{"award-number":["1KL2TR002374"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10067-024-06890-y","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T21:22:51Z","timestamp":1707340971000},"page":"1093-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sj\u00f6gren\u2019s disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities"],"prefix":"10.1007","volume":"43","author":[{"given":"Bradley R.","family":"Bohman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter S.","family":"Dowds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temisan E.","family":"Blagogee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Ike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-4185","authenticated-orcid":false,"given":"Sara S.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"issue":"1","key":"6890_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G et al (2022) Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med 22(1):9\u201325. https:\/\/doi.org\/10.1007\/s10238-021-00728-6","journal-title":"Clin Exp Med"},{"issue":"5","key":"6890_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"5","key":"6890_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3414\/me17-01-0051","volume":"56","author":"N Brusselaers","year":"2017","unstructured":"Brusselaers N, Lagergren J (2017) The Charlson Comorbidity Index in Registry-based Research. Methods Inf Med 56(5):401\u2013406. https:\/\/doi.org\/10.3414\/me17-01-0051","journal-title":"Methods Inf Med"},{"issue":"12","key":"6890_CR4","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57(12):1288\u20131294. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.03.012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"6890_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dorner T et al (2015) Validation of EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74(5):859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204615","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6890_CR6","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","volume":"1","author":"R Seror","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A et al (2015) EULAR Sjogren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1(1):e000022. https:\/\/doi.org\/10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"issue":"6","key":"6890_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A et al (2011) EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 70(6):968\u2013972. https:\/\/doi.org\/10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6890_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/rheumatology\/kev354","volume":"55","author":"AG Singh","year":"2016","unstructured":"Singh AG, Singh S, Matteson EL (2016) Rate, risk factors and causes of mortality in patients with Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 55(3):450\u2013460. https:\/\/doi.org\/10.1093\/rheumatology\/kev354","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6890_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Solans R, Fraile G, Su\u00e1rez-Cuervo C, Casanovas A et al (2016) Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 75(2):348\u2013355. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206418","journal-title":"Ann Rheum Dis"},{"key":"6890_CR10","doi-asserted-by":"publisher","first-page":"102062","DOI":"10.1016\/j.eclinm.2023.102062","volume":"61","author":"P Brito-Zer\u00f3n","year":"2023","unstructured":"Brito-Zer\u00f3n P, Flores-Ch\u00e1vez A, Horv\u00e1th IF, Rasmussen A, Li X, Olsson P et al (2023) Mortality risk factors in primary Sj\u00f6gren syndrome: a real-world, retrospective, cohort study. EClinicalMedicine 61:102062. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102062","journal-title":"EClinicalMedicine"},{"key":"6890_CR11","doi-asserted-by":"publisher","unstructured":"Papageorgiou A, Ziogas DC, Mavragani CP, Zintzaras E, Tzioufas AG, Moutsopoulos HM et al (2015) Predicting the outcome of Sjogren's syndrome-associated non-Hodgkin's lymphoma patients. PLoS One 10(2). https:\/\/doi.org\/10.1371\/journal.pone.0116189","DOI":"10.1371\/journal.pone.0116189"},{"key":"6890_CR12","doi-asserted-by":"publisher","first-page":"1048684","DOI":"10.3389\/fcvm.2022.1048684","volume":"9","author":"CL Zippel","year":"2022","unstructured":"Zippel CL, Beider S, Kramer E, Konen FF, Seeliger T, Skripuletz T et al (2022) Premature stroke and cardiovascular risk in primary Sj\u00f6gren\u2019s syndrome. Front Cardiovasc Med 9:1048684. https:\/\/doi.org\/10.3389\/fcvm.2022.1048684","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6890_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 American college of rheumatology\/european league against rheumatism classification criteria for primary sjogren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"6890_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/annrheumdis-2014-eular.4399","volume":"73","author":"R Seror","year":"2014","unstructured":"Seror R, Gottenberg JE, Bootsma H, Saraux A, Theander E, Ramos-Casals M et al (2014) Defining disease activity sates and minimal clinically important improvement (Mcii) with the eular primary sjogren\u2019s syndrome disease activity index (Essdai). Ann Rheum Dis 73:144\u2013145. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.4399","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6890_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.55563\/clinexprheumatol\/xef8uz","volume":"39 Suppl 133","author":"G Cafaro","year":"2021","unstructured":"Cafaro G, Perricone C, Riccucci I, Bursi R, Calvacchi S, Alunno A et al (2021) Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sj\u00f6gren\u2019s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 39 Suppl 133(6):107\u201313. https:\/\/doi.org\/10.55563\/clinexprheumatol\/xef8uz","journal-title":"Clin Exp Rheumatol"},{"key":"6890_CR16","doi-asserted-by":"publisher","unstructured":"\u0141uczak A, Ma\u0142ecki R, Kulus M, Madej M, Szahidewicz-Krupska E, Doroszko A (2021) Cardiovascular risk and endothelial dysfunction in primary sjogren syndrome is related to the disease activity. Nutrients 13(6). https:\/\/doi.org\/10.3390\/nu13062072","DOI":"10.3390\/nu13062072"},{"issue":"35","key":"6890_CR17","doi-asserted-by":"publisher","first-page":"e26164","DOI":"10.1097\/md.0000000000026164","volume":"100","author":"P Chabert","year":"2021","unstructured":"Chabert P, Danjou W, Mezidi M, Berthiller J, Bestion A, Fred AA et al (2021) Short- and long-term prognosis of acute critically ill patients with systemic rheumatic diseases: A retrospective multicentre study. Medicine (Baltimore) 100(35):e26164. https:\/\/doi.org\/10.1097\/md.0000000000026164","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6890_CR18","first-page":"721","volume":"33","author":"Y Atisha-Fregoso","year":"2015","unstructured":"Atisha-Fregoso Y, Rivera-Vicencio Y, Ba\u00f1os-Pelaez M, Hern\u00e1ndez-Molina G (2015) Main causes and risk factors for hospitalisation in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 33(5):721\u2013725","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"6890_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.55563\/clinexprheumatol\/mvcai5","volume":"39 Suppl 133","author":"MG Sandoval-Flores","year":"2021","unstructured":"Sandoval-Flores MG, Chan-Campos I, Hern\u00e1ndez-Molina G (2021) Factors influencing the EULAR Sj\u00f6gren\u2019s Syndrome Patient-Reported Index in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 39 Suppl 133(6):153\u20138. https:\/\/doi.org\/10.55563\/clinexprheumatol\/mvcai5","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"6890_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/mr\/roac066","volume":"33","author":"Z Bai","year":"2023","unstructured":"Bai Z, Hu C, Zhong J, Dong L (2023) Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysis. Mod Rheumatol 33(4):792\u2013802. https:\/\/doi.org\/10.1093\/mr\/roac066","journal-title":"Mod Rheumatol"},{"issue":"5","key":"6890_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/art.39534","volume":"68","author":"AL Tomi","year":"2016","unstructured":"Tomi AL, Belkhir R, Nocturne G, Desmoulins F, Berge E, Pavy S et al (2016) Brief report: Monoclonal gammopathy and risk of lymphoma and multiple myeloma in patients with primary sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 68(5):1245\u20131250. https:\/\/doi.org\/10.1002\/art.39534","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"6890_CR22","doi-asserted-by":"publisher","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","volume":"21","author":"H Zhong","year":"2022","unstructured":"Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y et al (2022) Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis. Autoimmun Rev 21(5):103084. https:\/\/doi.org\/10.1016\/j.autrev.2022.103084","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6890_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/03009742.2019.1634221","volume":"49","author":"A Heus","year":"2020","unstructured":"Heus A, Arends S, Van Nimwegen JF, Stel AJ, Nossent GD, Bootsma H (2020) Pulmonary involvement in primary Sj\u00f6gren\u2019s syndrome, as measured by the ESSDAI. Scand J Rheumatol 49(1):38\u201346. https:\/\/doi.org\/10.1080\/03009742.2019.1634221","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"6890_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/thy.2007.0398","volume":"19","author":"M Zeher","year":"2009","unstructured":"Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sj\u00f6gren\u2019s syndrome. Thyroid 19(1):39\u201345. https:\/\/doi.org\/10.1089\/thy.2007.0398","journal-title":"Thyroid"},{"issue":"3","key":"6890_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/RHU.0b013e3181d52a28","volume":"16","author":"N Alfaris","year":"2010","unstructured":"Alfaris N, Curiel R, Tabbara S, Irwig MS (2010) Autoimmune thyroid disease and Sj\u00f6gren syndrome. J Clin Rheumatol 16(3):146\u2013147. https:\/\/doi.org\/10.1097\/RHU.0b013e3181d52a28","journal-title":"J Clin Rheumatol"},{"key":"6890_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230x-2-21","volume":"2","author":"MJ Kaplan","year":"2002","unstructured":"Kaplan MJ, Ike RW (2002) The liver is a common non-exocrine target in primary Sj\u00f6gren\u2019s syndrome: a retrospective review. BMC Gastroenterol 2:21. https:\/\/doi.org\/10.1186\/1471-230x-2-21","journal-title":"BMC Gastroenterol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06890-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T11:15:06Z","timestamp":1708600506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6890"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06890-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval waived based on nature of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Support: This work was supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant 1KL2TR002374. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Hunter S. Dowds received a summer research award from the Herman and Gwendolyn Shapiro Foundation in support of the research he provided.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}},{"value":"All authors in this study deny relevant financial and nonfinancial competing interests. SSM receives unrelated consulting fees from Novartis, BMS, Otsuka, Visterra, Horizon, Kiniksa, Target RWE, iCell.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}